Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E R Becker

Showing results (61-70 of 67) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 67 results.
The American Journal of Managed Care|January 6, 2000
The changing healthcare market and how it has influenced the treatment of cardiovascular disease--Part 1E R Becker, D C Morris, S D Culler, et al.
The Annals of Thoracic Surgery|September 22, 2001
Comparing clinical outcomes in high-volume and low-volume off-pump coronary bypass operation programsP P Brown, M J Mack, A W Simon, et al.
The Journal of Invasive Cardiology|April 4, 2000
Benchmarking cardiac catheterization laboratories: the impact of patient age, gender and risk factors on variable costs, device costs, total time and procedural time in 53 catheterization laboratoriesE R Becker, D Cohen, S D Culler, et al.
The American Journal of Managed Care|January 6, 2000
The changing healthcare market: outlook for the future of cardiovascular disease treatment--Part 2E R Becker, D C Morris, S D Culler, et al.
The American Journal of Cardiology|September 12, 2000
Impact of patient characteristics, complications, and facility volume on the costs and time of cardiac catheterization and coronary angioplasty in 70 catheterization laboratoriesD J Cohen, E R Becker, S D Culler, et al.
The American Journal of Cardiology|July 30, 1999
Can cardiovascular clinical characteristics be identified and outcome models be developed from an in-patient claims database?W S Weintraub, C Deaton, L Shaw, et al.
The American Journal of Cardiology|March 11, 1999
Economics, health-related quality of life, and cost-effectiveness methods for the TACTICS (Treat Angina With Aggrastat [tirofiban]] and Determine Cost of Therapy with Invasive or Conservative Strategy)-TIMI 18 trialW S Weintraub, S D Culler, A Kosinski, et al.
Pageof 7

Showing results (61-70 of 67) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 67 results.
The American Journal of Managed Care|January 6, 2000
The changing healthcare market and how it has influenced the treatment of cardiovascular disease--Part 1E R Becker, D C Morris, S D Culler, et al.
The Annals of Thoracic Surgery|September 22, 2001
Comparing clinical outcomes in high-volume and low-volume off-pump coronary bypass operation programsP P Brown, M J Mack, A W Simon, et al.
The Journal of Invasive Cardiology|April 4, 2000
Benchmarking cardiac catheterization laboratories: the impact of patient age, gender and risk factors on variable costs, device costs, total time and procedural time in 53 catheterization laboratoriesE R Becker, D Cohen, S D Culler, et al.
The American Journal of Managed Care|January 6, 2000
The changing healthcare market: outlook for the future of cardiovascular disease treatment--Part 2E R Becker, D C Morris, S D Culler, et al.
The American Journal of Cardiology|September 12, 2000
Impact of patient characteristics, complications, and facility volume on the costs and time of cardiac catheterization and coronary angioplasty in 70 catheterization laboratoriesD J Cohen, E R Becker, S D Culler, et al.
The American Journal of Cardiology|July 30, 1999
Can cardiovascular clinical characteristics be identified and outcome models be developed from an in-patient claims database?W S Weintraub, C Deaton, L Shaw, et al.
The American Journal of Cardiology|March 11, 1999
Economics, health-related quality of life, and cost-effectiveness methods for the TACTICS (Treat Angina With Aggrastat [tirofiban]] and Determine Cost of Therapy with Invasive or Conservative Strategy)-TIMI 18 trialW S Weintraub, S D Culler, A Kosinski, et al.
Pageof 7